serotonin reuptake inhibitors

Early Neurological Outcome of Young Infants Exposed to Selective Serotonin Reuptake Inhibitors During Pregnancy: Results From the Observational SMOK Study.

Published June 21, 2013

Early Neurological Outcome of Young Infants Exposed to Selective Serotonin Reuptake Inhibitors during Pregnancy: Results from the Observational SMOK Study.

PLoS One. 2013; 8(5): e64654
de Vries NK, van der Veere CN, Reijneveld SA, Bos AF

Use of selective… Continue reading →

Relationships Among Cognition, Emotion, and Motivation: Implications for Intervention and Neuroplasticity in Psychopathology.

Published June 20, 2013

Relationships among cognition, emotion, and motivation: implications for intervention and neuroplasticity in psychopathology.

Front Hum Neurosci. 2013; 7: 261
Crocker LD, Heller W, Warren SL, O’Hare AJ, Infantolino ZP, Miller GA

Emotion-cognition and motivation-cognition relationships and related brain mechanisms… Continue reading →

Incidence and Risk Factors of Chronic Daily Headache in Young Adolescents: A School Cohort Study.

Published June 19, 2013

Incidence and Risk Factors of Chronic Daily Headache in Young Adolescents: A School Cohort Study.

Pediatrics. 2013 Jun 17;
Lu SR, Fuh JL, Wang SJ, Juang KD, Chen SP, Liao YC, Wang YF

OBJECTIVES:This study investigated the incidence and… Continue reading →

Examining the Relationship Between Food Thought Suppression and Binge Eating Disorder.

Published June 13, 2013

Examining the relationship between food thought suppression and binge eating disorder.

Compr Psychiatry. 2013 Jun 7;
Barnes RD, Masheb RM, White MA, Grilo CM

Food thought suppression, or purposely attempting to avoid thoughts of food, is related to a… Continue reading →

I Am a Young Woman Who Is Depressed All the Time but I Dont Want to Take Medicine How Can I Do That With Out M

Published June 10, 2013

by Michelle Griffiths

Question by petite26phoenix: I am a young woman who is depressed all the time but i dont want to take medicine how can i do that with out m
edicine.i just want to be the way i… Continue reading →

Effectiveness of Miltefosine Treatment in Targeting Anti-Leishmanial HO-1/Nrf-2-Mediated Oxidative Responses in Visceral Leishmaniasis Patients.

Published June 4, 2013

Effectiveness of miltefosine treatment in targeting anti-leishmanial HO-1/Nrf-2-mediated oxidative responses in visceral leishmaniasis patients.

J Antimicrob Chemother. 2013 May 31;
Das S, Pandey K, Rabidas VN, Mandal A, Das P

OBJECTIVES: Miltefosine, an alkylphosphocholine anti-cancer drug, exhibits direct activity… Continue reading →

Efficacy of Add-on Deep Transcranial Magnetic Stimulation in Comorbid Alcohol Dependence and Dysthymic Disorder: Three Case Reports.

Published June 1, 2013

Efficacy of Add-On Deep Transcranial Magnetic Stimulation in Comorbid Alcohol Dependence and Dysthymic Disorder: Three Case Reports.

Prim Care Companion CNS Disord. 2013; 15(1):
Rapinesi C, Kotzalidis GD, Serata D, Casale AD, Bersani FS, Solfanelli A, Scatena P, Raccah… Continue reading →

Amphetamine Elicits Opposing Actions on Readily Releasable and Reserve Pools for Dopamine.

Published May 15, 2013

Amphetamine elicits opposing actions on readily releasable and reserve pools for dopamine.

PLoS One. 2013; 8(5): e60763
Covey DP, Juliano SA, Garris PA

Amphetamine, a highly addictive drug with therapeutic efficacy, exerts paradoxical effects on the fundamental communication modes… Continue reading →

Changes in Capacity to Consent Over Time in Patients Involved in Psychiatric Research.

Published May 11, 2013

Changes in capacity to consent over time in patients involved in psychiatric research.

Br J Psychiatry. 2013 May 9;
Palmer BW, Savla GN, Roesch SC, Jeste DV

BACKGROUND: Informed consent is a key element of ethical clinical research. Patients… Continue reading →

In Vitro Selection of Mutant HDM2 Resistant to Nutlin Inhibition.

Published May 9, 2013

In Vitro Selection of Mutant HDM2 Resistant to Nutlin Inhibition.

PLoS One. 2013; 8(4): e62564
Wei SJ, Joseph T, Sim AY, Yurlova L, Zolghadr K, Lane D, Verma C, Ghadessy F

HDM2 binds to the p53 tumour suppressor and… Continue reading →